Description

6-Bromo-2-(4-Methoxyphenyl)-3-Methylquinoline-4-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its specific quinoline-based molecular structure. This compound is of significant value in the research and development of novel active pharmaceutical ingredients (APIs), particularly for its role as a key building block in medicinal chemistry. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of complex molecules for therapeutic applications.

Application

• Pharmaceutical Intermediate: A critical building block in the multi-step synthesis of potential drug candidates, especially those targeting specific biological pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes to develop new therapeutic agents.
• Organic Synthesis Reference Standard: Serves as a high-purity standard for analytical method development and validation in QC laboratories.
• Academic & Institutional Research: Employed in universities and research institutes for studying heterocyclic chemistry and developing novel synthetic methodologies.
• Precursor for Functionalized Quinolines: The reactive bromo and carboxylic acid groups allow for further chemical modifications to create a library of derivatives for screening.

Basic Information

Product Name	6-Bromo-2-(4-Methoxyphenyl)-3-Methylquinoline-4-Carboxylic Acid
CAS No.	354539-71-2
Molecular Formula	C₁₈H₁₄BrNO₃
Molecular Weight	372.21 g/mol
Synonyms	6-Bromo-2-(4-methoxyphenyl)-3-methyl-4-quinolinecarboxylic acid; 4-Quinolinecarboxylic acid, 6-bromo-2-(4-methoxyphenyl)-3-methyl-; 6-Bromo-2-(p-methoxyphenyl)-3-methylquinoline-4-carboxylic acid; 354539-71-2; 6-Bromo-2-(4-methoxyphenyl)-3-methylquinoline-4-carboxylic acid; 3-Methyl-6-bromo-2-(4-methoxyphenyl)quinoline-4-carboxylic acid
EINECS	Contact for details

Quality Control

Our 6-Bromo-2-(4-Methoxyphenyl)-3-Methylquinoline-4-Carboxylic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. The container should be kept tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Melting Point	Contact for details
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.